Recently, the news that the chairman of Tongce Medical, known as "Tooth Mao", and netizens choked each other attracted the attention of the market. In the Shanghai and Shenzhen stock markets, investors often complain because they are dissatisfied with certain aspects of listed companies, which is really common, and listed companies often ignore them. But what I didn't expect was that the chairman of Tongce Medical was intimidated by netizens.
According to the third quarterly report of Tongce Medical, the operating income in the first three quarters of this year was 2.136 billion yuan, an increase of 44.16% year-on-year; the net profit was 620 million yuan, an increase of 55.09% year-on-year. Such a performance increase is actually quite good. However, the performance of the third quarter of this year was not satisfactory, and the listed company achieved operating income of 819 million yuan in the third quarter, an increase of 12.44% year-on-year; and achieved a net profit of 269 million yuan, an increase of 5.88% year-on-year. Compared with the growth rate in the first three quarters, the performance growth of Tongce Medical in the third quarter has slowed down significantly.
Tongce Medical, known as "Tooth Mao", has performed well in its stock price in previous years. In August 2017, its stock price fell at a minimum of 22.34 yuan, and on June 25 this year, the highest touched 421.99 yuan, during which the stock price rose nearly 18 times. Compared with the "first highest-priced stock" Guizhou Moutai, the stock price performance of Tongce Medical in the same period is significantly much stronger.
However, this time and time. Since June 25 this year, Tongce Medical's stock price has begun to fall. On September 3, it fell to 214.68 yuan, and compared with the highest price, the decline has been "waist cut". Although there has been a rebound since then, on October 14 and 15, two consecutive trading days fell to a halt, and the loss of investors is self-evident.
The growth rate of Tongce Medical's performance in the third quarter, as well as the poor performance of the stock price, has also aroused the doubts of some investors. Some netizens claimed that "Tongce medical stock is the best teaching material for killing pigs in the stock market", and even wrote Tongce Medical as Tongce Medical, saying that the essence is the same as the submersible shares. Everything is fake, but the pig killing funds behind the scenes have been unregulated for a long time. In this regard, the chairman of Tongce Medical directly hardened, saying that such investors are not welcome to be shareholders of listed companies, and it is a shame to buy Tongce Medical shares. Judging only from the wording of both sides, both sides are a bit excessive.
In fact, the slowdown in the growth rate of Tongce Medical in the third quarter of this year is not without reasons. According to the explanation of the listed company, due to the impact of the new crown epidemic in the first quarter of 2020, the demand for customer medical treatment was released in the second and third quarters, and the single quarter of 2020 had a higher year-on-year base, which objectively led to a slowdown in the performance growth rate in the third quarter of this year. The explanation of listed companies actually works.
But investors questioned Tongce Healthcare, which clearly has other factors. Tongce Medical disclosed the three quarterly report data after the close of the market on October 14, but the stock fell to a halt "in advance" on the same day, so the market questioned that its data was leaked out in advance, and there was also a suspicion of insider trading, otherwise what should be explained? Even based on this, it is understandable for investors to vent their dissatisfaction.
In fact, whether it is investors venting their dissatisfaction or the chairman of Tongce Medical choking back, the core of the problem is because of the word "interest". Slower performance growth, falling stock prices, or even insider trading can lead to damage to investors' interests. And for two consecutive trading days, investors lost a lot of money in the short term. Investors vent their dissatisfaction, which is closely related to the shrinking wealth.
However, netizens said that Tongce Medical is a pig killing plate, as well as other statements, which will obviously affect the image of listed companies, and may have a negative impact on stock prices, and eventually affect the interests of listed companies and major shareholders. Based on this, it seems reasonable for some people on the side of listed companies to fight back. However, the chairman of a listed company in Tangtang recoiled netizens and used words that were very "hot eyes" in some aspects, which really made people speechless. In fact, this is not only related to the image of the chairman himself, but also the image of the listed company.
The mutual choking between the chairman of the listed company and netizens has also triggered the discussion of many investors, and I personally believe that in this matter, for investors, there is obviously a problem of careless stock selection. On the one hand, in recent years, the stock price of Tongce Medical has risen significantly, and it should not have been the object of investment. On the other hand, recently, tongce medical stock price has continued to adjust, and the hidden risks are self-evident. Therefore, for such stocks, it is best to stay away.
For listed companies, the chairman personally went out to choke with netizens, which is obviously a bit small. In response to the dissatisfaction of investors, listed companies actually only need to do their own daily operations, improve their performance, netizens complain, vent dissatisfaction, etc., can not be too serious.